Skip to main content
Clinical Trials/NCT06508255
NCT06508255
Recruiting
Not Applicable

Time-restricted Eating and Cognition (ChronoBEAT)

German Institute of Human Nutrition1 site in 1 country35 target enrollmentMay 17, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Time Restricted Eating
Sponsor
German Institute of Human Nutrition
Enrollment
35
Locations
1
Primary Endpoint
Behaviour: risk propensity on a decision-making task
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to investigate how time-restricted eating (TRE), more specifically TRE at different times (early vs late in the day), influences brain activity, behavior, decision-making, food intake, physical activity, the gut microbiome and metabolic processes. The study intervention procedure is a replication of that described in Peters et al. (2021).

Detailed Description

This study aims to investigate the effects of different time-restricted eating (TRE) interventions on decision-making, brain activity and related processes in an all female cohort over 8 weeks. The study will have a within-subjects, randomised, crossover design, involving two TRE interventions with a comparable feeding and fasting window of 8:16h respectively- early TRE (eating window: 08:00-16:00) and late TRE (eating window: 13:00-21:00). After completing a screening visit, participants will complete a two-week observational phase in which they record their habitual food intake, as well as sleep and physical activity assessment. After this observational phase, participants will be randomly assigned to one of two study arms (early TRE/late TRE or late TRE/early TRE). Here they will complete both TRE interventions for two weeks each, separated by a washout phase of two weeks. During these phases they will record their food intake and physical activity and sleep will be assessed. The participants will be invited for 4 laboratory study visits during this time, at the beginning and end of each TRE intervention.

Registry
clinicaltrials.gov
Start Date
May 17, 2024
End Date
March 2025
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Soyoung Q Park

Prof. Dr. Soyoung Q Park (Principal Investigator)

German Institute of Human Nutrition

Eligibility Criteria

Inclusion Criteria

  • right-handed
  • legally competent
  • physically and mentally healthy
  • BMI: 19-35 kg/m²
  • fluent in reading and speaking German

Exclusion Criteria

  • weight change \>5% of body weight during the last 3 months
  • pregnancy or breastfeeding
  • allergies (inclusion possible after consultation with study doctor)
  • history of cardiovascular disease (myocardial infarction, stroke, hypertension, hypotension) in the last year
  • severe psychiatric condition, including drug addiction and depression
  • impaired renal or liver function
  • dementia or other severely debilitating cognitive disease
  • history of or current eating disorders (e.g., Bulimia nervosa, Anorexia nervosa, Orthorexia nervosa, Binge-Eating disorder)
  • chronic diseases (e.g., Morbus Crohn, Colitis Ulcerosa)
  • metabolic disorders (e.g., metabolic syndrome, diabetes type 1 or 2)

Outcomes

Primary Outcomes

Behaviour: risk propensity on a decision-making task

Time Frame: 8 weeks

The choice (accept/reject) between a risk/gamble or safe option, based on a task paradigm by Liu et al. (2021)

Behaviour: Daily food intake

Time Frame: 8 weeks

Self-reported food intake, recorded via FoodApp or handwritten food diary

Brain: blood-oxygen-level-dependent (BOLD) signal changes

Time Frame: 8 weeks

BOLD signal changes on a whole-brain level and in predefined regions of interest assessed using fMRI

Fasting glucose

Time Frame: 8 weeks

Blood samples

Insulin

Time Frame: 8 weeks

Blood samples

Large Neutral Amino Acids (LNAAs)

Time Frame: 8 weeks

Blood samples

Secondary Outcomes

  • Sleep Efficiency (SE)(8 weeks)
  • Wake After Sleep Onset (WASO)(8 weeks)
  • Sleep Fragmentation Index(8 weeks)
  • Moderate to Vigorous Physical Activity (MVPA)(8 weeks)
  • Step Count(8 weeks)
  • Questionnaire assessing stress(8 weeks)
  • Progesterone(8 weeks)
  • Total Sleep Time (TST)(8 weeks)
  • Total movement(8 weeks)
  • Non-sedentary Time(8 weeks)
  • Energy Expenditure(8 weeks)
  • Sleep Onset Latency (SOL)(8 weeks)
  • Questionnaire assessing impulsive behaviour(8 weeks)
  • Gut microbiome composition(8 weeks)
  • Cortisol(8 weeks)
  • Estradiol(8 weeks)
  • Questionnaire assessing sleep quality(8 weeks)
  • Glucose tolerance(8 weeks)
  • Questionnaire assessing risk-taking behaviour(8 weeks)
  • Questionnaire assessing momentary impulsive behaviour(8 weeks)
  • Questionnaire assessing behavioural inhibition and activation(8 weeks)
  • Ghrelin(8 weeks)
  • Questionnaires assessing chronotype(8 weeks)
  • Questionnaire assessing emotional eating(8 weeks)
  • Questionnaire assessing social decision-making(8 weeks)
  • Questionnaire assessing wellbeing(8 weeks)
  • Decision-making(8 weeks)
  • Daily questions monitoring intervention effects(8 weeks)
  • Questionnaire assessing intuitive eating(8 weeks)
  • Questionnaire assessing food cravings(8 weeks)
  • Questionnaire assessing mood(8 weeks)
  • Questionnaire assessing interoception(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials